Flora Coppolani is an experienced venture capital investor and investor relations specialist currently serving at CapHorn Invest within the Anaxago Group since September 2022. She specializes in guiding startups from seed to Series C funding rounds, with a particular focus on climatetech and healthtech sectors. Prior experience: •Partner, iyrtro (2020 – 2021) •Director of Acceleration, …
Archives du type de publication : Team Showcase
Prof. Pierre Vandamme, MD, PhD
Prof. Pierre Van Damme is the former Chairman of the Vaccine & Infectious Disease Institute (VAXINFECTIO) at the University of Antwerp, and head of the Centre for the Evaluation of Vaccination with more than 25 years of experience in vaccinology Expertise: • Conducted more than 350 vaccine trials at the Center for the Evaluation of …
Prof. Odile Launay, MD, PhD
Odile Launay is Professor of Infectious diseases at the University of Paris. She is the Director of the Clinical Investigation Center in Vaccinology (CIC Cochin Pasteur), the only French clinical investigation center dedicated to vaccinal research based in Paris, since it is creation in 2005 and Coordinator of the French Innovative Clinical Network in Vaccinology …
Dr W. Ripley Ballou, MD
Dr W. Ripley Ballou currently serves as Principal Investigator for the ADVANCE Program at IAVI, he also held several leadership positions at GSK Vaccines globally and in the US, and with the Gates Foundation. Rip brings over 30 years of experience in the clinical development of vaccines. Expertise: • Experience with multiple clinical development for …
Dr Bernard Fritzell, MD
Dr Bernard Fritzell is an independent consultant with 35 years’ experience in the clinical development of vaccines Expertise: • Major Contributions to the understanding of polysaccharide conjugate vaccines including Haemophilus influenza type B, meningococcal group A & C and Streptococcus pneumoniae and associated vaccination strategies • Contributions to the clinical development of Hepatitis B, rabies …
Prof. Geert Leroux-Roels, MD, PhD
Prof. Geert Leroux-Roels is an Emeritus professor of Ghent University, Faculty of Medicine & Health Science, founder and former director of the Center for Vaccinology (CEVAC) at Ghent University and University Hospital. He acts as a private consultant and keeps supporting CEVAC activities as clinical investigator and scientific advisor. Expertise: • Conducted more than 250 …
Prof. Sir Andrew J McMichael
Sir Andrew J MCMICHAEL is a Professor of Molecular Medicine at the Nuffield Department of Medicine at the University of Oxford, UK. For more than 50 years he has worked on cytotoxic T-lymphocytes (CTL) responses against viruses, especially influenza. • He first showed that human cytotoxic T lymphocyte (CTL) responses to influenza virus were HLA …
Dr. Tim Mosmann
Dr. Tim Mosmann is Director of the human immunology center at the University of Rochester, with more than 40 years of experience and major contributions in T cell mediated immunity Expertise • Established a high-throughput proliferation and cytotoxicity assay for cytokines • Used this assay to show that there were discrete patterns of cytokines produced …
Dr Fergal Hill, MD
Dr. Fergal HILL is co-inventor of the pro-immunogenic tags oligoDOM® (OVX313) in its first and second generation. He has published in prominent international journals and is the coauthor of more than 15 patents or patent applications. Prior experience: • CSO, IMAXIO (2000-2017) • Researcher, European Molecular Biology Laboratory, Heidelberg, Germany (1999-2000) • Researcher, Laboratory of …
Dr Nathalie Garcon, Pharm D, PhD
Dr. Nathalie Garçon has more than 30 years of expertise in vaccinology, from research to manufacturing, in particular immunology, adjuvant and formulation technologies Expertise: • 5 new innovation projects selected, with implementation path defined and milestone established for go/no go decision • Restructuration of North America RD, with downsizing from 4 to 2 sites, and …